Abstract: The present invention is directed to compounds of formula (I) wherein variables W, X, Y, D, A, n, R1, R2 and R9 are as defined in the description.

Abstract: Various embodiments of a patient removal system are provided for evacuating a patient during an emergency. The patient removal systems may be used to transport the patient while the patient is on a mattress, or the patient removal systems may be used to transport the patient without the mattress. The patient removal systems permit caregivers to transport patients out of danger or harm without requiring patient support devices to be transported along with the patients.

Abstract: A dynamic content assembly system, including an application and underlying database, with methods to support the creation, transformation and management of relationship information between resources and to enable dynamic assembly of content based on these relationships.

Abstract: Compounds that are antagonists of the VR1 receptor, having formula (I) or a pharmaceutically acceptable salt, prodrug, or salt of a prodrug thereof, wherein A1, A2, A3, A4, R7, R8, R9, X, Y, Z, L, n, and m, are as defined herein, and are useful in disorders prevented or ameliorated by inhibiting the VR1 receptor.

Abstract: Compounds having formula (I) or formula (II) or a pharmaceutically acceptable salt, prodrug, or salt of a prodrug thereof, wherein A, N, X, Y, R1, R2 and R3 are as defined in the specification. These compounds are particularly useful in the treatment of pain, inflammatory hyperalgesia, and urinary dysfunctions, such as bladder overactivity and urinary incontinence.

Abstract: The present invention relates to compounds of formula (I) that are novel VR1 antagonists useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence, or bladder overactivity.

Abstract: A bed for a person is provided. The bed includes a frame, a deck including a seat section and a foot section movable relative to the seat section. The bed further including a mechanism that control movement of the foot section relative to the seat section.

Abstract: A bed for a person is provided. The bed includes a frame, a deck, and a mattress. The bed further includes a plurality of foot-operated controls configured to control features of the bed.

Abstract: Compounds of formula (I) are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence, or bladder overactivity.

Abstract: A launch system for a hybrid vehicle includes a pump, an electronic throttle, a sensor, and a hybrid control module. The pump is driven by an internal combustion engine and provides pressurized fluid to a transmission. The electronic throttle selectively adjusts airflow to the internal combustion engine and current to an electric motor. The sensor detects when a brake pedal has been released. The hybrid control module increases pressure of the pressurized fluid and limits torque transfer from at least one of the internal combustion engine and the electric motor when the sensor detects that the brake pedal has been released until a predetermined condition has been met. The hybrid control module increases pressure of the pressurized fluid with the pump by increasing the revolutions of the internal combustion engine and limits torque to the transmission by retarding the responsiveness of the electronic throttle.

Abstract: Various embodiments of a patient removal system are provided for evacuating a patient during an emergency. The patient removal systems may be used to transport the patient while the patient is on a mattress, or the patient removal systems may be used to transport the patient without the mattress. The patient removal systems permit caregivers to transport patients out of danger or harm without requiring patient support devices to be transported along with the patients.

Abstract: A bed enclosure for a health care facility bed including a frame and a mattress to support a patient. The enclosure includes a shell and a frame to support the shell.

Abstract: Compounds of formula (I) are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity.

Abstract: The present invention relates to compounds of formula (I) that are novel VR1 antagonists useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence, or bladder overactivity.

Abstract: The present invention relates to compounds of formula (I-VII) or a pharmaceutically acceptable salt or prodrug thereof, in which A, L, R6, R7 and R8 are defined herein. The present invention also relates to methods of trating pain using these compounds and pharmaceutical compositions including these compounds.

Abstract: The present invention discloses novel compounds of general formula (I) or a pharmaceutically acceptable salt or prodrug thereof (in which X1—X5, R5—R8b, Z1-Z2 and Ar1 are defined herein), a method for inhibiting the VR1 receptor in mammals using these compounds, a method for controlling pain in mammals, and pharmaceutical compositions including those compounds and a process for making those compounds.

Abstract: The present invention relates to compounds of formula (I) that useful in treating pain.

Abstract: A portable container is disclosed with a pivotal compartment which may be accessed when a cover of the portable container is in an open and a closed position. The compartment is pivotally secured to a side section of the container bottom. The interior of the pivotal compartment may be accessed through a top and bottom wall of the cover section.